Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating an autologous dendritic cell vaccine in patients with soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Sunitinib in Certain Subtypes of Soft Tissue Sarcomas [Phase 2]
Phase 2 trial of sunitinib in certain subtypes of soft tissue sarcoma was terminated; results posted in 2019. No further details provided in…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer [Phase 1]
Phase 1 study of AR-42 (pan-DAC inhibitor) with pazopanib in advanced renal cell carcinoma and soft tissue sarcoma was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating apatinib in combination with chemotherapy for soft tissue sarcoma is ongoing with status not specified.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent soft tissue sarcoma has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma [Phase 1]
Phase 1 clinical trial update of olaratumab (LY3012207) in participants with soft tissue sarcoma has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib hydrochloride plus toripalimab in unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients [Phase 2]
Phase 2 trial investigating anlotinib hydrochloride in combination with epirubicin and ifosfamide for soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma [NA]
Trial investigating pazopanib followed by chemotherapy and surgery for adult soft tissue sarcoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update investigating anlotinib hydrochloride plus liposomal doxorubicin for locally advanced or metastatic soft tissue sarcoma…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy [Phase 2]
Phase 2 trial update for anlotinib hydrochloride in advanced soft tissue sarcoma patients not receiving chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update for TH-302 in locally advanced unresectable or metastatic soft tissue sarcoma; trial terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies [Phase 2]
Phase 2 trial evaluating liposomal vincristine in pediatric and adolescent patients with relapsed malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) [Phase 2]
Phase 2 clinical trial evaluating vorinostat for efficacy and tolerability in advanced, metastatic soft tissue sarcoma completed.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating haploidentical stem cell transplantation with NK cell therapy in high-risk solid tumors, including neurobl…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial updating response-based treatment for children with unresectable localized soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas. [Phase 2]
Phase II trial of NGR-hTNF in combination with doxorubicin for metastatic soft tissue sarcoma completed.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma [Phase 3]
Phase 3 trial comparing observation versus post-surgery radiotherapy after complete excision in soft tissue sarcoma; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas [Phase 2]
Phase II study evaluating tivozanib in patients with metastatic and non-resectable soft tissue sarcomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma [Phase 3]
A Phase 3 trial comparing trabectedin to best supportive care in soft tissue sarcoma has completed.
-
FDA approval · 2018-06-29FDA Approved: YONDELIS — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for YONDELIS (trabectedin) from Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study [Phase 2]
This entry reports a Phase 2 trial evaluating radiotherapy concurrent with apatinib for advanced soft tissue and bone sarcomas of the head a…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial investigating LY573636-Sodium for metastatic soft tissue sarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Trabectedin First Line Therapy In Unfit Sarcoma Study [Phase 2]
Phase 2 trial evaluating trabectedin as first-line therapy in patients with metastatic or locally advanced soft tissue sarcoma who are unfit…
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease
A completed clinical trial sponsored by Duke University evaluated quality of life in patients with soft tissue sarcoma presenting with metas…